Publication | Closed Access
The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome
41
Citations
23
References
2006
Year
Functional Gastrointestinal DisorderAntibioticsGastrointestinal PharmacologyMedicineDouble-blind TrialGastroenterology10-Week Follow-up PeriodIrritable Bowel SyndromePharmacotherapyNonabsorbed Oral AntibioticUlcerative ColitisPharmacologyAntimicrobial ResistanceDrug Resistance
In this double-blind trial, 87 patients with the irritable bowel syndrome were randomly assigned to either rifaximin (400 mg 3 times daily) or placebo for 10 days. Over a 10-week follow-up period, ...
| Year | Citations | |
|---|---|---|
Page 1
Page 1